GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aion Therapeutic Inc (OTCPK:ANTCF) » Definitions » Net Change in Cash

ANTCF (Aion Therapeutic) Net Change in Cash : $-0.24 Mil (TTM As of Jan. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Aion Therapeutic Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Aion Therapeutic's Net Change in Cash for the three months ended in Jan. 2025 was $-0.06 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jan. 2025 was $-0.24 Mil.

Aion Therapeutic Net Change in Cash Historical Data

The historical data trend for Aion Therapeutic's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aion Therapeutic Net Change in Cash Chart

Aion Therapeutic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Net Change in Cash
Get a 7-Day Free Trial -0.72 -0.30 -0.19 - 0.05

Aion Therapeutic Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 -0.21 0.01 0.01 -0.06

Aion Therapeutic Net Change in Cash Calculation

Aion Therapeutic's Net Change in Cash for the fiscal year that ended in Apr. 2024 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-0.618+-0.211+0.819+0.06
=0.05

Aion Therapeutic's Net Change in Cash for the quarter that ended in Jan. 2025

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-0.031+0+0.165+-0.19
=-0.06

Net Change in Cash for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aion Therapeutic Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Aion Therapeutic's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Aion Therapeutic Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aion Therapeutic Inc (OTCPK:ANTCF) » Definitions » Net Change in Cash
Comparable Companies
XCNQ:RIPP XCNQ:AYUR XCNQ:HERB XCNQ:FFNT XCNQ:CVGR TSXV:DHB XCNQ:BBM XCNQ:XBRA NEOE:TILT XCNQ:IMCC ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
AION:Canada
Address
700 West Georgia Street, Suite 2200, Vancouver, BC, CAN, V7Y 1K8
Website
https://www.aiontherapeutic.com
Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery. During the year ended the Company had one operating segment, being health and wellness, dedicated to delivering state-of-the-art water filtration solutions. Geographically company earns revenue from USA.